-
Mashup Score: 1Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit - 7 month(s) ago
Novo Nordisk plans to stop a trial of Ozempic to treat kidney failure after an interim analysis showed the drug would succeed.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Pharmalittle: FDA approves first gene therapy for Duchenne muscular dystrophy; states join FTC to stop Amgen deal - 11 month(s) ago
The states of California, New York, Illinois, Minnesota, Washington, and Wisconsin have joined a Federal Trade Commission lawsuit to stop Amgen from buying Horizon Therapeutics.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
GSK reached a settlement with a man who claimed its Zantac heartburn medication caused his cancer, avoiding the first such case that was about to go to trial in the U.S.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Pharmalittle: U.S. Senate committee passes PBM bills; Pfizer CEO predicts pharma will sue over Medicare price negotiations - 12 month(s) ago
The U.S. Senate health committee passed a package of bills aimed at speeding generic drug competition and reining in pharmacy benefit managers.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: FDA proposes more rigorous cancer drug trials for accelerated approval; insurers not covering obesity meds for kids - 1 year(s) ago
The FDA proposed cancer drug developers in most cases conduct more rigorous trials to seek accelerated approval.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
In a setback to GSK, a California judge ruled that a consumer cleared a key legal hurdle and can proceed with a lawsuit claiming the Zantac heartburn was linked to cancer.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Moderna pays NIH for Covid vaccine technique; first trial over Zantac cancer claims is postponed - 1 year(s) ago
Moderna has paid $400 million to the U.S. government for the rights to a chemical technique used in its successful Covid-19 vaccines.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Pharmalittle: Biden administration pitches three drug-pricing experiments; GSK kept quiet on Zantac cancer risk - 1 year(s) ago
Over four decades, GSK chose to keep quiet on the cancer risks of the recalled heartburn medication Zantac.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Above The Fold in Healthcare - 1 year(s) ago
The Front Page of Healthcare News on the Internet by C. Michael Gibson MD
Source: paper.liCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0FDA scolds company that raised red flags over impurities in many widely used medicines - 1 year(s) ago
The FDA inspected Valisure facilities after a stretch in which the company openly pushed the agency to do more to test drugs for impurities.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
Pharmalot.. Pharmalittle.. Good Morning: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit & More news.. https://t.co/Ey0fume7Uu #pharma #Zantac #weightloss #Ozempic #Wegovy #vaccines $GSK $NVO $AZN